HPG-7233

N/A

Report date: 2023/09/21 17:19:32
NME

Base Information

Drug NameHPG-7233
Drug Alias NameHPG-7233HPG7233
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor agonists
TargetsThyroid hormone receptor
Therapy Area/IndicationsDyslipidemiasMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHepagene Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHepagene Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDyslipidemiasMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A